139 related articles for article (PubMed ID: 28464270)
1. Effect of Intravenous Alfentanil on Nonpainful Thermally Induced Hyperalgesia in Healthy Volunteers.
Schifftner C; Schulteis G; Wallace MS
J Clin Pharmacol; 2017 Sep; 57(9):1207-1214. PubMed ID: 28464270
[TBL] [Abstract][Full Text] [Related]
2. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
Leung A; Wallace MS; Ridgeway B; Yaksh T
Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
[TBL] [Abstract][Full Text] [Related]
3. Postdelivery of alfentanil and ketamine has no effect on intradermal capsaicin-induced pain and hyperalgesia.
Wallace MS; Braun J; Schulteis G
Clin J Pain; 2002; 18(6):373-9. PubMed ID: 12441831
[TBL] [Abstract][Full Text] [Related]
4. Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia.
Wallace MS; Ridgeway B; Leung A; Schulteis G; Yaksh TL
J Clin Pharmacol; 2002 Jan; 42(1):70-80. PubMed ID: 11808827
[TBL] [Abstract][Full Text] [Related]
5. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo.
Jørum E; Warncke T; Stubhaug A
Pain; 2003 Feb; 101(3):229-235. PubMed ID: 12583865
[TBL] [Abstract][Full Text] [Related]
6. Interaction of physostigmine and alfentanil in a human pain model.
Wehrfritz AP; Ihmsen H; Schmidt S; Müller C; Filitz J; Schüttler J; Koppert W
Br J Anaesth; 2010 Mar; 104(3):359-68. PubMed ID: 20047897
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the relative potency of fentanyl buccal tablet to intravenous morphine in healthy volunteers using a thermally induced hyperalgesia pain model.
Saunders DL; Messina J; Darwish M; Xie F; Leary KJ; Cantilena LR
J Clin Pharmacol; 2012 Jun; 52(6):870-9. PubMed ID: 21646442
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
[TBL] [Abstract][Full Text] [Related]
9. Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects.
Sethna NF; Liu M; Gracely R; Bennett GJ; Max MB
Anesth Analg; 1998 Jun; 86(6):1250-6. PubMed ID: 9620514
[TBL] [Abstract][Full Text] [Related]
10. A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine.
Koppert W; Dern SK; Sittl R; Albrecht S; Schüttler J; Schmelz M
Anesthesiology; 2001 Aug; 95(2):395-402. PubMed ID: 11506112
[TBL] [Abstract][Full Text] [Related]
11. Placebo-controlled comparison of a morphine/dextromethorphan combination with morphine on experimental pain and hyperalgesia in healthy volunteers.
Frymoyer AR; Rowbotham MC; Petersen KL
J Pain; 2007 Jan; 8(1):19-25. PubMed ID: 17113353
[TBL] [Abstract][Full Text] [Related]
12. Effect of a high-dose target-controlled naloxone infusion on pain and hyperalgesia in patients following groin hernia repair: study protocol for a randomized controlled trial.
Pereira MP; Werner MU; Dahl JB
Trials; 2015 Nov; 16():511. PubMed ID: 26554360
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model.
Wallace MS; Quessy S; Schulteis G
Pharmacol Biochem Behav; 2004 Jun; 78(2):349-55. PubMed ID: 15219777
[TBL] [Abstract][Full Text] [Related]
14. Effect of remifentanil on pain and secondary hyperalgesia associated with the heat--capsaicin sensitization model in healthy volunteers.
Petersen KL; Jones B; Segredo V; Dahl JB; Rowbotham MC
Anesthesiology; 2001 Jan; 94(1):15-20. PubMed ID: 11135717
[TBL] [Abstract][Full Text] [Related]
15. Human experimental pain models 3: heat/capsaicin sensitization and intradermal capsaicin models.
Modir JG; Wallace MS
Methods Mol Biol; 2010; 617():169-74. PubMed ID: 20336422
[TBL] [Abstract][Full Text] [Related]
16. The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males.
Tompkins DA; Smith MT; Bigelow GE; Moaddel R; Venkata SL; Strain EC
Clin J Pain; 2014 Jan; 30(1):36-45. PubMed ID: 23446076
[TBL] [Abstract][Full Text] [Related]
17. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia.
Comelon M; Raeder J; Stubhaug A; Nielsen CS; Draegni T; Lenz H
Br J Anaesth; 2016 Apr; 116(4):524-30. PubMed ID: 26934941
[TBL] [Abstract][Full Text] [Related]
18. Alfentanil, but not amitriptyline, reduces pain, hyperalgesia, and allodynia from intradermal injection of capsaicin in humans.
Eisenach JC; Hood DD; Curry R; Tong C
Anesthesiology; 1997 Jun; 86(6):1279-87. PubMed ID: 9197296
[TBL] [Abstract][Full Text] [Related]
19. Effect of Pregabalin on the Median Effective Plasma Concentration of Intravenous Alfentanil in Capsaicin-Induced Pain.
Wallace MS
Pain Med; 2021 Dec; 22(12):3072-3079. PubMed ID: 34329455
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of postoperative pain: clinical indications for a contribution of central neuronal sensitization.
Dirks J; Møiniche S; Hilsted KL; Dahl JB
Anesthesiology; 2002 Dec; 97(6):1591-6. PubMed ID: 12459689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
